Ashima Intrinsic Value
Ashima (ASHIMASYN) median intrinsic value is ₹14.43 from 2 valuation models (range ₹5–₹14), vs current price ₹15.65 — -7.8% downside (Trading Near Calculated Value), margin of safety -8.5%. See Ashima P/B valuation to compare market price against book value per share.
ASHIMASYN Valuation Methods Summary — DCF, Graham Number & P/E
Ashima intrinsic value across 2 models vs current price ₹15.65 — upside/downside and value range per method. Check Ashima market cap to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹14.43 | ₹12.99 - ₹15.87 | -7.8% | Book Value/Share: ₹14.43, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹4.70 | ₹4.23 - ₹5.17 | -70.0% | Revenue/Share: ₹1.46, P/S: 0.8x |
ASHIMASYN Intrinsic Value vs Market Price — All Valuation Models
Ashima fair value range ₹5–₹14 vs current market price ₹15.65 across 2 valuation models. For current market price and key ratios, visit Ashima screener.
ASHIMASYN Intrinsic Value Analysis — Undervalued or Overvalued?
Ashima median intrinsic value ₹14.43, current price ₹15.65 — Trading Near Calculated Value by 7.8%, margin of safety -8.5%.
What is the intrinsic value of ASHIMASYN?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Ashima (ASHIMASYN) is ₹14.43 (median value). With the current market price of ₹15.65, this represents a -7.8% variance from our estimated fair value.
The valuation range spans from ₹4.70 to ₹14.43, indicating ₹4.70 - ₹14.43.
Is ASHIMASYN undervalued or overvalued?
Based on our multi-method analysis, Ashima (ASHIMASYN) appears to be trading near calculated value by approximately 7.8%.
ASHIMASYN Financial Health — Key Ratios vs Industry Benchmarks
Ashima financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -10.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -90.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.05x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ASHIMASYN Cash Flow Quality — Operating & Free Cash Flow
Ashima operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-40 Cr | ₹-61 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-20 Cr | ₹-20 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-39 Cr | ₹-41 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-26 Cr | ₹-26 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-8 Cr | ₹-12 Cr | Negative Cash Flow | 3/10 |